YOKNEAM, Israel and PLYMOUTH MEETING, Pennsylvania, March 25
/PRNewswire-FirstCall/ -- Galil Medical, a global cryotherapy company,
today announced that Martin J. Emerson has been appointed President and
Chief Executive Officer. Galil Medical is a market leader in cryotherapy
technology for the minimally invasive treatment of cancerous and
non-cancerous tumours. Mr. Emerson is an experienced and successful medical
device industry executive, and was most recently President and CEO of
American Medical Systems (AMS). He will be replacing Chen Barir, who will
continue to serve on the Galil Medical Board of Directors.

    Chen Barir commented, "Galil Medical is very pleased to have been able
to attract an executive with the leadership experience and stature of Marty
Emerson. We are confident that Marty will be able to help Galil Medical
sustain the growth that has been recorded since our December 2006
reorganisation and recapitalisation financing."

    "I am very excited to be joining Galil Medical," said Mr. Emerson. "The
company has developed innovative cryotherapy solutions to treat prostate
cancer and renal tumours and has a promising product pipeline for the
Women's Health and Interventional Radiology markets. I look forward to
working with the talented team to expand the opportunities for Galil
Medical's industry leading technology around the globe."

    Mr. Emerson has a strong track record of over 20 years of
accomplishments in the medical device industry, most recently as President
and Chief Executive Officer of AMS. During his tenure at AMS, he held
executive roles including Vice President and General Manager of
International, Executive Vice President of Global Sales and Marketing and
Chief Operating Officer. Prior to joining AMS, he held senior roles in the
overseas operations for several American-based companies including Baxter
International and Boston Scientific.

    About Galil Medical

    Galil Medical develops, manufactures and markets innovative products
utilising a proprietary cryotherapy platform that incorporates powerful
freezing technology and revolutionary 17-gauge cryoablation needle design.
Galil Medical systems enable minimally invasive, targeted ablation of
benign and cancerous tumours while ensuring rapid recovery and enhanced
quality of life for patients. The Presice(TM) Cryoablation System features
multi-point thermal sensors (MTS) and advanced IceVue(TM) planning software
for excellent procedure control in treating prostate and renal cancer. The
SeedNet(TM) system provides physicians with an easy-to-use cryoablation
solution to precisely ablate tumours while protecting adjacent structures.

    Galil Medical is a global medical device company with offices in
Yokneam, Israel; Plymouth Meeting, Pennsylvania; and London, shareholders
include Thomas, McNerney & Partners, The Vertical Group, Investor Growth
Capital, Elron Electronic Industries Ltd. (NASDAQ: ELRN) and RDC Rafael
Development Corporation, Ltd. For more information, please visit
http://www.galilmedical.com



    Pam Schwartz
    Communications Manager
    Galil Medical
    T: +972-4-909-3273
    M: +972-52-625-4443
    F: +972-4-959-1077
    pam.schwartz@galilmedical.com

Link to this page: